Stat3 activation in combination with nf-kappab inhibition induces tolerogenic dendritic cells with high therapeutic potential to attenuate collagen-induced arthritis

dc.contributor.authorPrado, Carolina
dc.contributor.authorUgalde, Valentina
dc.contributor.authorGonzález, Hugo
dc.contributor.authorFigueroa, Alicia
dc.contributor.authorLópez, Ernesto
dc.contributor.authorLladser, Alvaro
dc.contributor.authorPacheco, Rodrigo
dc.date.accessioned2023-04-17T18:41:54Z
dc.date.available2023-04-17T18:41:54Z
dc.date.issued2019
dc.descriptionIndexación Scopuses
dc.description.abstractDendritic cells (DCs) have the ability to induce tolerance or inflammation in response to self-Antigens, which makes them fundamental players in autoimmunity. In this regard, immunogenic DCs produce IL-12 and IL-23 favouring the acquisition of Th1 and Th17 inflammatory phenotypes, respectively, by autoreactive CD4+ T-cells, thus promoting autoimmunity. Conversely, tolerogenic DCs produce IL-10 and TGF-β, inducing the generation of CD4+ T-cells with suppressive activity (Treg), which promote tolerance to self-constituents. Previous studies have shown that STAT3 signalling in DCs attenuates the production of proinflammatory cytokines, whilst NF-kB activation promotes it. In this study, we aimed to generate DCs displaying strong and constitutive tolerogenic profile to be used as immunotherapy in autoimmunity. To this end, we transduced bone marrowderived DCs with lentiviral particles codifying for a constitutively active version of STAT3 (constitutively active STAT3 (STAT3ca)) or with a constitutive repressor of NF-kB (IkBα superrepressor (IkBαSR)), and their therapeutic potential was evaluated in a mouse model of arthritis induced by collagen (CIA). Our results show that STAT3ca transduction favoured the production of the anti-inflammatory mediator IL-10, whereas IkBαSR transduction attenuated the expression of the proinflammatory cytokine IL-23 in DCs. Moreover, both STAT3ca-Transduced and IkBαSR-Transduced DCs separately exerted a mild but significant therapeutic effect reducing the severity of CIA development. Furthermore, when DCs were transduced with both STAT3ca and IkBSR together, they reduced CIA manifestation significantly stronger than when transduced with only STAT3ca or IkBαSR separately. These results show STAT3 and NF-kB as two important and complementary regulators of the tolerogenic behaviour of DCs, which should be considered as molecular targets in the design of DC-based suppressive immunotherapies for the treatment of autoimmune disorders.es
dc.identifier.citationJournal of Immunology Research Volume 2019 2019 Article number 1982570es
dc.identifier.doi10.1155/2019/1982570en
dc.identifier.issn2314-8861
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/48623
dc.language.isoenes
dc.publisherJournal of Immunology Researches
dc.rights.licenseAttribution 4.0 International (CC BY 4.0)en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectAnimalses
dc.subjectArthritis, Experimentales
dc.subjectAutoimmunityes
dc.subjectCD4-Positive T-Lymphocyteses
dc.subjectDendritic Cellses
dc.subjectHumanses
dc.subjectImmune Tolerancees
dc.subjectInflammationes
dc.subjectInterleukin-10es
dc.subjectInterleukin-12es
dc.subjectMalees
dc.subjectMicees
dc.subjectNF-kappa Bes
dc.subjectSTAT3 Transcription Factores
dc.subjectTh1 Cellses
dc.titleStat3 activation in combination with nf-kappab inhibition induces tolerogenic dendritic cells with high therapeutic potential to attenuate collagen-induced arthritises
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Stat3-activation-in-combination-with-nfkappab-inhibition-induces-tolerogenic-dendritic-cells-with-high-therapeutic-potential-to-attenuate-collageninduced-arthritisJournal-of-Immunology-Research.pdf
Tamaño:
4.15 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: